Labandero, Venancio B.

HRN: 12-13-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
CIPROFLOXACIN 500MG (TAB)
04/10/2024
04/17/2024
PO
500mg
OD
Gastroenteritis
Checking Final Appropriateness 
04/11/2024
CEFTRIAXONE 1G (VIAL)
04/11/2024
04/17/2024
IV
2g
OD
Perforated PUD
Checking Final Appropriateness 
04/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/12/2024
04/18/2024
IV
500mg
Q8
Perforated PUD
Waiting Final Action 
04/15/2024
METRONIDAZOLE 500MG (TAB)
04/15/2024
04/21/2024
PO
500mg
TID
Perforated PUD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: